Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular Disease: Prospective 5 Years of Follow-Up and Apolipoprotein(a) Characterization.
Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):2019-27. doi: 10.1161/ATVBAHA.116.307983. Epub 2016 Jul 14.
Arterioscler Thromb Vasc Biol. 2016.
PMID: 27417585
Lipoprotein apheresis in patients with maximally tolerated lipid-lowering therapy, lipoprotein(a)-hyperlipoproteinemia, and progressive cardiovascular disease: prospective observational multicenter study.
Leebmann J, Roeseler E, Julius U, Heigl F, Spitthoever R, Heutling D, Breitenberger P, Maerz W, Lehmacher W, Heibges A, Klingel R; Pro(a)LiFe Study Group*.
Leebmann J, et al. Among authors: breitenberger p.
Circulation. 2013 Dec 17;128(24):2567-76. doi: 10.1161/CIRCULATIONAHA.113.002432. Epub 2013 Sep 20.
Circulation. 2013.
PMID: 24056686
Item in Clipboard
Quality of life in patients with idiopathic sudden hearing loss: comparison of different therapies using the Medical Outcome Short Form (36) Health Survey questionnaire.
Mösges R, Köberlein J, Erdtracht B, Klingel R; RHEO-ISHL Study Group.
Mösges R, et al.
Otol Neurotol. 2008 Sep;29(6):769-75. doi: 10.1097/MAO.0b013e31817e5d03.
Otol Neurotol. 2008.
PMID: 18725858
Clinical Trial.
Item in Clipboard
Cite
Cite